MAP of 65 or 20% of baseline? What Blood Pressure Target Should You Actually Use Under Anesthesia?
Here's What the Evidence Says
We are taught a lot of different blood pressure targets for patients under anesthesia. A percentage of baseline. A hard MAP number. A systolic floor. But when you step back and ask what the evidence actually supports, the picture is both clearer and more nuanced than most of us were taught.
Let's walk through what we know, what we don't, and how to think about hypotension management in real time.
One Thing We Know for Sure: Low Is Bad
If there is a single takeaway from the last decade of perioperative research, it is this. Intraoperative hypotension is associated with worse outcomes.
Large observational studies have consistently linked low intraoperative blood pressure to postoperative complications, particularly acute kidney injury and myocardial injury. The signal becomes especially clear once mean arterial pressure drops below roughly 60 to 65 mmHg.
And the relationship is not all-or-nothing. It is dose-dependent in two directions:
Depth matters. The lower the MAP, the stronger the association with injury. A MAP of 55 carries more risk than a MAP of 62.
Duration matters. The longer the pressure stays low, the worse the outcomes. Even 10 to 20 minutes of a MAP below 60 has been associated with harm.
In other words, both how low and how long count. Brief, quickly corrected dips are not the same as sustained hypotension, but sustained hypotension deserves real attention.
What the Guidelines Recommend
Professional guidance reflects this evidence. Recommendations supported by the American Heart Association and American College of Cardiology generally point toward maintaining an intraoperative MAP of at least 60 to 65 mmHg, or a systolic blood pressure around 90 mmHg, as a reasonable floor for most patients. 1
The logic is straightforward. Below that range, the risk of organ hypoperfusion climbs, and the evidence linking that zone to kidney and cardiac injury is strong enough to treat it as a line you generally do not want to cross.
But Higher Is Not Automatically Better
Here is where clinical reasoning has to take over from reflex.
It is tempting to assume that if low is bad, higher must be protective. The evidence does not support that leap. A trial targeting a MAP at or above 80 mmHg did not demonstrate improvement in major outcomes compared with a more modest target near 60. 2
The same applies to the traditional rule of keeping blood pressure within 10 to 20 percent of baseline. It is a reasonable starting heuristic, but chasing higher numbers for their own sake has not been shown to improve outcomes, and it commits you to more vasopressor and more intervention without a clear payoff.
So the evidence lands in a practical middle ground:
A MAP around 65 is a sensible floor. Defend it.
Avoid sustained hypotension above almost anything else.
Do not assume higher targets help. Pushing well above the floor adds intervention without proven benefit for most patients.
(Most of this evidence comes from adult noncardiac surgery, so these targets should not be automatically applied to cardiac, neuro, obstetric, pediatric, major vascular, or shock physiology without clinical judgment.)
Why This Matters at the Bedside
The reason this nuance is worth internalizing is that hypotension decisions happen fast. The pressure drops, and you respond. In that moment, it is easy to anchor on a single number.
But a target is a floor, not a goal to overshoot. The skill is in recognizing sustained hypotension early, treating the underlying cause rather than just the number, and resisting the urge to drive pressure higher than the evidence supports.
This is also where individual physiology enters the conversation. A chronically hypertensive patient, a patient with known cerebrovascular disease, or a patient with poor cardiac reserve may warrant a different floor than a young, healthy patient. Population-level targets are a starting point. Clinical judgment tailors them.
Common Pitfalls
Treating the Number Instead of the Trend
A single low reading is not the same as sustained hypotension. Look at how long the pressure has been low and where it is heading before reacting.
Chasing High Targets
Driving MAP well above 65 without a specific indication adds vasopressor exposure and intervention without clear outcome benefit for most patients.
Ignoring Duration
Because harm accumulates over time, a "mild" hypotension that lingers for 20 minutes may matter more than a brief deeper dip that is corrected quickly.
Applying One Target to Every Patient
Baseline pressure, comorbidities, and the type of surgery all influence what an appropriate floor looks like for a given patient.
Practical Takeaways for SRNAs and CRNAs
Treat a MAP of roughly 65 as your floor for most patients, and act decisively when you approach it.
Prioritize avoiding sustained hypotension. Depth and duration both drive risk.
Do not assume higher is safer. Targets well above the floor have not shown outcome benefit in major trials.
Individualize. Adjust your floor based on the patient's baseline and comorbidities.
Treat the cause, not just the monitor. Ask why the pressure is low before deciding how to raise it.
FAQs
What MAP should I target under anesthesia?
For most patients, a MAP of at least 60 to 65 mmHg is a reasonable floor. The emphasis should be on avoiding sustained drops below that range.
Is intraoperative hypotension really linked to organ injury?
Observational evidence consistently associates intraoperative hypotension with postoperative acute kidney injury and myocardial injury, especially as MAP falls below 60 to 65 and as the duration of hypotension increases.
If low pressure is bad, should I aim for a higher MAP to be safe?
Not necessarily. In POISE-3, a strategy targeting intraoperative MAP ≥80 did not improve major vascular outcomes compared with a strategy targeting MAP ≥60 in high-risk adult noncardiac surgery patients. That does not mean higher targets are never appropriate; it means routine higher targets have not shown clear benefit for broad populations.
Does the 10 to 20 percent of baseline rule still apply?
It remains a common starting heuristic, but maintaining higher pressures based on baseline alone has not been shown to improve outcomes. Use it as a guide, not a guarantee.
How long is too long for a low MAP?
Risk accumulates with time. Even 10 to 15 minutes of a MAP below 60 has been associated with harm, so sustained hypotension should be addressed promptly.
Should every patient have the same blood pressure target?
No. Baseline blood pressure, cardiovascular disease, and surgical context all influence what an appropriate floor is for an individual patient.
Conclusion
The evidence on intraoperative blood pressure tells a consistent story. Low blood pressure, especially sustained low blood pressure, is associated with worse outcomes, and a MAP around 65 is a reasonable floor to defend. At the same time, higher is not automatically better, and chasing elevated targets has not been shown to improve outcomes.
The real skill is not memorizing a single number. It is recognizing sustained hypotension early, understanding why it is happening, and matching your response to the patient in front of you.
So here is the question worth asking yourself: how aggressively are you managing hypotension, and is your approach grounded in the evidence or in habit?
References
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A., Berger, J. S., Chow, B., Dakik, H. A., de las Fuentes, L., Eisenstein, E. L., Gerhard-Herman, M., Ghadimi, K., Kachulis, B., Leclerc, J., Lee, C. S., Macaulay, T. E., … Williams, K. A., Sr. (2024). 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM guideline for perioperative cardiovascular management for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 150(19), e351–e442. DOI: 10.1161/CIR.0000000000001285.
Walsh, M., Devereaux, P. J., Garg, A. X., Kurz, A., Turan, A., Rodseth, R. N., Cywinski, J., Thabane, L., & Sessler, D. I. (2013). Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: Toward an empirical definition of hypotension. Anesthesiology, 119(3), 507–515. DOI: 10.1097/ALN.0b013e3182a10e26.
Sun, L. Y., Wijeysundera, D. N., Tait, G. A., & Beattie, W. S. (2015). Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology, 123(3), 515–523. DOI: 10.1097/ALN.0000000000000765.
Salmasi, V., Maheshwari, K., Yang, D., Mascha, E. J., Singh, A., Sessler, D. I., & Kurz, A. (2017). Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: A retrospective cohort analysis. Anesthesiology, 126(1), 47–65. DOI: 10.1097/ALN.0000000000001432.
Wesselink, E. M., Kappen, T. H., Torn, H. M., Slooter, A. J. C., & van Klei, W. A. (2018). Intraoperative hypotension and the risk of postoperative adverse outcomes: A systematic review. British Journal of Anaesthesia, 121(4), 706–721. DOI: 10.1016/j.bja.2018.04.036.
POISE-3 Trial Investigators and Study Groups. (2023). Hypotension-avoidance versus hypertension-avoidance strategies in noncardiac surgery: An international randomized controlled trial. Annals of Internal Medicine, 176(5), 605–614. DOI: 10.7326/M22-3157.
Futier, E., Lefrant, J.-Y., Guinot, P.-G., Godet, T., Lorne, E., Cuvillon, P., Bertran, S., Leone, M., Pastene, B., Piriou, V., Molliex, S., Albanese, J., Julia, J.-M., Tavernier, B., Imhoff, E., Bazin, J.-E., Constantin, J.-M., Pereira, B., & Jaber, S., for the INPRESS Study Group. (2017). Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: A randomized clinical trial. JAMA, 318(14), 1346–1357. DOI: 10.1001/jama.2017.14172.
